Accessibility Menu
Fisher & Paykel Healthcare logo

Fisher & Paykel Healthcare

(OTC) FSPKF

Current Price$22.23
Market Cap$13.23B
Since IPO (2003)+241%
5 Year+16%
1 Year+11%
1 Month+11%

Fisher & Paykel Healthcare Financials at a Glance

Market Cap

$13.23B

Revenue (TTM)

NZ$4.57B

Net Income (TTM)

NZ$999.87M

EPS (TTM)

$0.47

P/E Ratio

48.09

Dividend

$0.41

Beta (Volatility)

0.26 (Low)

Price

$22.23

Volume

1,548

Open

$18.84

Previous Close

$22.23

Daily Range

$18.84 - $22.23

52-Week Range

$18.84 - $25.65

Estimated Earnings Date

May 25, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fisher & Paykel Healthcare

Industry

Healthcare Equipment and Supplies

Employees

7,661

CEO

Lewis George Gradon

Headquarters

Auckland, 2013, NZ

FSPKF Financials

Key Financial Metrics (TTM)

Gross Margin

64.16%

Operating Margin

28.52%

Net Income Margin

20.03%

Return on Equity

22.84%

Return on Capital

29.51%

Return on Assets

16.42%

Earnings Yield

2.08%

Dividend Yield

1.83%

Payout Ratio

53.85%

Stock Overview

Market Cap

$13.23B

Shares Outstanding

587.29M

Volume

1.55K

Avg. Volume

1.90K

Financials (TTM)

Gross Profit

NZ$2.62B

Operating Income

NZ$515.56M

EBITDA

NZ$1.75B

Operating Cash Flow

NZ$1.45B

Capital Expenditure

-NZ$316.61M

Free Cash Flow

NZ$1.13B

Cash & ST Invst.

NZ$465.72M

Total Debt

NZ$146.10M

Fisher & Paykel Healthcare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

NZ$1.25B

+33.2%

Gross Profit

NZ$810.95M

+45.3%

Gross Margin

64.83%

N/A

Market Cap

$13.23B

N/A

Market Cap/Employee

$1.90M

N/A

Employees

6,978

N/A

Net Income

NZ$258.06M

+920.0%

EBITDA

NZ$457.04M

+85.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

NZ$465.72M

+468.0%

Total Debt

NZ$146.10M

-22.7%

Accounts Receivable

NZ$346.24M

+34.6%

Inventory

NZ$330.58M

+3.2%

Long Term Debt

NZ$113.30M

+22.0%

Short Term Debt

NZ$32.80M

-65.9%

Return on Assets

16.42%

N/A

Return on Invested Capital

28.31%

N/A

Free Cash Flow

NZ$299.57M

+36.0%

Operating Cash Flow

NZ$421.58M

+54.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ERFSFEurofins Scientific SE
$77.54-2.40%
CHJTFCSPC Pharmaceutical Group Limited
$0.98+0.00%
ALBHFAlibaba Health Information Technology Limited
$0.41-2.64%
ALBBYAlibaba Health Information Technology Limited
$8.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%

Questions About FSPKF

What is the current price of Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare is trading at $22.23 per share.

What is the 52-week range for Fisher & Paykel Healthcare?

Over the past 52 weeks, Fisher & Paykel Healthcare has traded between $18.84 and $25.65.

How much debt does Fisher & Paykel Healthcare have?

As of the most recent reporting period, Fisher & Paykel Healthcare reported total debt of NZ$83.34M.

How much cash does Fisher & Paykel Healthcare have on hand?

Fisher & Paykel Healthcare reported NZ$263.03M in cash and cash equivalents in its most recent financial results.

What is Fisher & Paykel Healthcare’s dividend yield?

Fisher & Paykel Healthcare currently has a dividend yield of 1.83%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.